Warning: getimagesize(https://magazine.pharmamkt.net/wp-content/uploads/2020/09/logo-group.jpg): failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /home/luciamun/public_html/magazine/wp-content/plugins/td-cloud-library/shortcodes/header/tdb_header_logo.php on line 792

The largest community of pharma leaders

Novartis, LEO Pharma & MSD discuss what HCPs want – and how you can give it to them

Dear Colleague

Long gone are the days of knocking on doors with a smile and a promise – today, success with HCPs depends on how well you use data insights to create content that feels tailored and trustworthy. But how can you ensure your customer experience offer bucks the one-size-fits-all trend?
eyeforpharma have brought global experts from NovartisLEO Pharma and MSD International together for a webinar to discuss how you can use observational data to build a personalized, value-driven HCP engagement strategy and stay ahead of the competition.

Sign-up to join the free webinar and gain insights on:

  • What HCPs actually want from pharma – what the latest data is telling us, and how current engagement strategies match up
  • The impact of personalized approaches – how you can implement best practice strategies to build stronger relationships
  • Engaging the person and the demographic – which sophisticated data-driven approaches will enable you to exceed the expectations of HCPs as individuals and as a wider collective group
Join these experts on October 10 at 2pm London / 3pm Paris / 9am NY. Sign-up for free here.

If you can’t make it, sign-up anyway and you’ll receive the “on demand” version.

If you have any questions about this webinar, please contact Hannah Brady, Global Projects Director, at eyeforpharma on hbrady@eyeforpharma.com.

Best regards,
Lucy Muñiz MD
Editor The Pharmaceutical Marketing Group
http://magazine.pharmamkt.net
0FansLike
0FollowersFollow
0FollowersFollow
0FollowersFollow

Recent Articles

Asana BioSciences to Present Positive Results from Phase 2b Study of Oral JAK/SYK Inhibitor Gusacitinib in Patients with Chronic Hand Eczema in the Late-Breaking...

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Asana BioSciences’ Oral Gusacitinib (ASN002) demonstrates rapid and significant...

Aptinyx Announces Proposed Public Offering of Common Stock

EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing...

Xeris Pharmaceuticals Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging...

AppliedVR Receives FDA Breakthrough Device Designation to Treat Pain with Digital Therapeutic

LOS ANGELES--(BUSINESS WIRE)-- #chronicpain--AppliedVR, a pioneer advancing the next generation of...

After Meeting with FDA, Guided Therapeutics to Start Study in Support of its Application for FDA Approval

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)-- #FDA--After Meeting with FDA, Guided Therapeutics to...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.